Recent advances and potential pharmacological activities of benzimidazole derivatives

Der Pharma Chemica

Volumn 3, Issue 2, 2011, Pages 172-193

  Srikanth, L ^a   Varun Raj, V ^b   Raghunandan, N ^c   Venkateshwerlu, L ^b  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

^b Vikas College of Pharmacy   (India)

^c Balaji Institute of Pharmaceutical Sciences   (India)

Author keywords

Anti hypertensive agent; Benzimidazole derivatives; Potential pharmacological activities

Indexed keywords

(1H BENZIMIDAZOL 2 YLSULFANYL)THIAZOLIDIN 4 ONE DERIVATIVE; 1 (1H BENZIMIDAZOL 2 YL) 3 PHENYLPROP 2 EN 1 ONE; 1 BENZYL 2 PHENYL 1H BENZIMIDAZOLE; 1 ETHYL 2 [(3 NITROPHENOXY)METHYL] 1H BENZIMIDAZOLE; 1 PHENYL 3 (2 PHENYL 1 PROPYL 1H BENZIMIDAZOL 5 YL)THIOUREA; 2 (1H BENZIMIDAZOL 2 YLSULFANYL) N (4 OXO 2 PHENYL 1,3 THIAZOLIDIN 3 YL)ACETAMIDE; 2 (1H BENZIMIDAZOL 2 YLSULFANYL) N [2 (4 CHLOROPHENYL) 4 OXO 1,3 THIAZOLIDIN 3 YL]ACETAMIDE; 2 (1H BENZIMIDAZOL 2 YLSULFANYL) N [2 (4 HYDROXYPHENYL) 4 OXO 1,3 THIAZOLIDIN 3 YL]ACETAMIDE; 2 (1H BENZIMIDAZOL 2 YLSULFANYL) N [2 (4 METHYLPHENYL) 4 OXO 1,3 THIAZOLIDIN 3 YL]ACETAMIDE; 2 (1H BENZIMIDAZOL 2 YLSULFANYL) N [2 (FURAN 2 YL) 4 OXO 1,3 THIAZOLIDIN 3 YL]ACETAMIDE; 2 (4 METHYL 1,4 DIAZEPAN 1 YL) 1H BENZIMIDAZOLE; 2 (PHENOXYMETHYL) 1H BENZIMIDAZOLE; 2 [(4 BROMOPHENOXY)METHYL] 1H BENZIMIDAZOLE; 2 [(4 CHLORO 3 METHYLPHENOXY)METHYL] 1H BENZIMIDAZOLE; 2 [[(5 PHENYL 1,3,4 OXADIAZOL 2 YL)METHYL]SULFANYL] 1H BENZIMIDAZOLE; 2 [[[5 (4 CHLOROPHENYL) 1,3,4 OXADIAZOL 2 YL]METHYL]SULFANYL] 1H BENZIMIDAZOLE; 2 [[[5 (PYRIDIN 4 YL) 1,3,4 OXADIAZOL 2 YL]METHYL]SULFANYL] 1H BENZIMIDAZOLE; 4 [5 [(1H BENZIMIDAZOL 2 YLSULFANYL)METHYL] 1,3,4 OXADIAZOL 2 YL]ANILINE; 4 [5 [(1H BENZIMIDAZOL 2 YLSULFANYL)METHYL] 1,3,4 OXADIAZOL 2 YL]PHENOL; 4' (1H BENZIMIDAZOL 1 YLMETHYL)BIPHENYL 2 CARBOXYLIC ACID; 5 [5 [(1H BENZIMIDAZOL 2 YLSULFANYL)METHYL] 1,3,4 OXADIAZOL 2 YL]BENZENE 1,3 DIOL; BENZIMIDAZOLE DERIVATIVE; FLUCONAZOLE; GENTAMICIN; GLIBENCLAMIDE; ISONIAZID; METHYL [5 (PROPYLSULFANYL) 1H BENZIMIDAZOL 2 YL]CARBAMATE; N [2 (4 AMINOPHENYL) 4 OXO 1,3 THIAZOLIDIN 3 YL] 2 (1H BENZIMIDAZOL 2 YLSULFANYL)ACETAMIDE; RIFAMPICIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTICONVULSANT ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 79955728166     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. G.L. Gravatt, B.C. Baguley, W.R.Wilson, W.A. Denny, J. Med. Chem. 1994, 37, 4338-4345.
2. J.D. Geratz, F.M. Stevens, K.L. Polakoski, R.F. Parrish, Arch. Biochem. Biophys. 1979, 197, 551-559.
3. T.A. Fairley, R.R. Tidwell, I. Donkor, N.A. Naiman, K.A. Ohemeng, R.J. Lombardy, J.A. Bentley, M. Cory, J. Med. Chem. 1993, 36, 1746-1753.
4. B. George, E.P. Papadopoulos, J. Org. Chem. 1977, 42, 441-443.
5. H. Fujioka, K. Murai,Y. Ohba, A. Hiramatsu,Y. Kita, Tetrahedron Lett. 2005, 46, 2197-2199.
6. S. Peddibhotla, J.J. Tepe, Synthesis, 2003, 1433-1440.
7. D.H. Huh, H. Ryu, Y.G. Kim, Tetrahedron, 2004, 60, 9857-9862.
8. J.M. Mitchell, N.S. Finney, Tetrahedron Lett. 2000, 41, 8431-8434.
9. S.L. You, J.W. Kelly, Org. Lett. 2004, 6, 1681-1683.
10. Ramya V. Shingalapur, Kallappa M. Hosamani, S. Keri, European Journal of Medicinal Chemistry, 2010, 45, 1753-1759.
11. S. Hemalatha, T. Ayyappan, S. Shanmugam, S. Nagavalli, T.S. Kurubha, Indian Journal of Trade Knowledge, 2006, V, 468-470.
12. Vijaya B Reddy, Rajeev K Singla Varadaraj Bhat G and Gautham G Shenoy, Asian Journal of Research Chem. 2009, 2(2), 162-167.
13. Kamdar, G. C.; Chavda, A. C.; Parikh, A. R. J. Indian Chem. Soc. 1987, 64, 298.
14. L.L. Kruse, D.L. Ladd, P.B. Harrsch, F.L. McCabe, S.M. Mong, L. Faucette and R. Johnson, J. Med. Chem. 1989, 32, 409-417.
15. V.L. Khairnar. S.R. Lockhande and B.G.Khadse, Chemical Abstract, 1981, 95, 203.
16. I. Wiedemann, H. Peli, H. Justus, S. Adamus, V. Brantl, H. Lohamann, Arzneim- Forsch., Drug Res., 1985, 35, 964-969.
17. K. Kubo, Y. Kohara, E. Imamiya, Y. Sugiura, Y. Inada, Y. Furukawa, K.Nishikawa, T. Naka, J. Med. Chem. 1993, 36, 2182-2195.
18. V.J. Habernickel, Drugs made in Germany, 1992, 35, 97.
19. B. Can-Eke, M.O. Puskullu, E. Buyukbingol and M. Iscan, Chemico-Biological Interactions, 1998, 113, 65-77.
20. G. Ayhan-Kilcigil, C. Kus, T. Coban, B. Can-Eke and M. Iscan, Journal of Enzyme Inhibition and Medicinal Chemistry, 2004, 19, 129-135.
21. Guelguen, Archive Pharmacol. Res. 2004, 27, 156-163.
22. K. Ito, H. Kagaya, T. Fukuda, K. Yoshino and T. Nose, Arzneim. Forsch. 1982, 32, 49-55.
23. M. V. Kulkarni and V. D. Patil, Arch. Pharm. 1981, 314, 440-447.
24. Hiroyuki, Tsutomu, Nobuhide, Chem. Pharm. Bull. 1999, 47(11), 1573-1578.
25. Vitale G., Loriga M., Sanna G., Busonera B., La Colla P., Paglietti G. XVII Convegno Nazionale della Divisione di Chimica Farmaceutica della Società Chimica Italiana, Pisa, September 2004, 6-10, P197.
26. B.Kohl, E.Sturm, J.S.Blifinger,W.Alexander,S.V, J. Med. Chem., 1992, 35, 1049-1057.
27. S.Yamada,T.Goto, E.Shimanuki and S. Narita, Chem. Pharm. Bull., 1994, 42 (3), 718-20.
28. K.Bernhard, G.Gerhard, S.B.Joerg, O.Wolfgang, World Patent No.9501351, (1995).
29. G. Michael, S. George, S.J. Moo, US Patent No.6559167, (2003).
30. S.G. Reddy, P.P. Hegde, P.C.Ranjan, Het. Comm., 2005, 11(1), 23-28.